SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Genocea Biosciences Initiates a Phase 1/2a Study With Its Therapeutic Vaccine Candidate for Herpes Simplex Virus-2 (HSV-2)